Supplements
Supplements to JNCCN present a focused review of a particular topic. Examples of these special issues include final reports from an NCCN Task Force and summaries from medical conferences or symposia that are of interest to the practicing oncologist. These supplements may also present opportunities for readers to earn continuing medical education credit.
Supplements to JNCCN are subject to approval by the editorial board and undergo peer review.
2023
2022
2021
2020
2019
2018
2016
2014
2013
2012
2011
- NCCN Task Force Report: Optimizing Treatment of Advanced Renal Cell Carcinoma With Molecular Targeted Therapy
- NCCN Task Force Report: Tyrosine Kinase Inhibitor Therapy Selection in the Management of Patients With Chronic Myelogenous Leukemia
- JNCCN Special Edition: NCCN Oncology Pharmacy & Policy
- NCCN Biosimilars White Paper: Regulatory, Scientific, and Patient Safety Perspectives
- NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology
- NCCN Molecular Testing White Paper: Effectiveness, Efficiency, and Reimbursement
2010
- Addressing Challenges in Multiple Myeloma Management in an Era of New Therapeutics
- NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
- The Abu Dhabi Declaration: Adapted Application of NCCN Clinical Practice Guidelines in Oncology in the Middle East and North Africa Region
- NCCN Task Force Report: Specialty Pharmacy
- Preliminary Report: The Development of the NCCN Comparative Therapeutic Index™ as a Clinical Evaluative Process for Existing Data in Oncology
- Reassessing the Standard of Care in Indolent Lymphoma: A Clinical Update to Improve Clinical Practice
- JNCCN Special Edition: NCCN Oncology Pharmacy & Policy
2009
- NCCN Task Force: Management of Dermatologic and Other Toxicities Associated with EGFR Inhibition in Patients with Cancer
- NCCN Task Force: Clinical Utility of PET in a Variety of Tumor Types
- NCCN Task Force Report: Bone Health in Cancer Care
- NCCN Task Force Report: Molecular Markers in Leukemias and Lymphomas
- NCCN Task Force Report: Management of Neuropathy in Cancer
- NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry
- The Science and Practice of Bone Health in Oncology: Managing Bone Loss and Metastasis in Patients With Solid Tumors
- Epigenetic Modulation in Hematologic Malignancies: Challenges and Progress
- NCCN Task Force: Transfusion and Iron Overload in Patients With Myelodysplastic Syndromes
2008
2007
2006
